157 related articles for article (PubMed ID: 2195796)
21. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients].
Puppo F; Corsini G; Mangini P; Armani U; Piana A
Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916
[No Abstract] [Full Text] [Related]
22. [Studies on the pathogenic mechanism of beta-lactam hypersensitivity by the detection of leucocyte migration activating factor and leucocyte migration inhibitory factor].
Uno K
Arerugi; 1990 Dec; 39(12):1605-11. PubMed ID: 2096806
[TBL] [Abstract][Full Text] [Related]
23. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
[TBL] [Abstract][Full Text] [Related]
24. Cellular collaboration in the production of human leucocyte migration inhibition factor.
Weisbart RH; Yu DT; Billing R; Fan PT; Clements PJ; Paulus HE
Immunology; 1978 May; 34(5):815-9. PubMed ID: 306961
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous production of an inhibitor in vitro lymphocyte migration by lymphocytes from patients with Hodgkin's disease and mycosis fungoides.
Skopińska-Rónzewska E; Zółtowska A; Dziewulska-Bokiniec A
Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):57-62. PubMed ID: 6756337
[No Abstract] [Full Text] [Related]
26. Activation of Fc receptor-bearing lymphocytes by immune complexes. I. Stimulation of lymphokine production by nonadherent human peripheral blood lymphocytes.
Neville ME; Lischner HW
J Immunol; 1982 Mar; 128(3):1063-9. PubMed ID: 6173417
[TBL] [Abstract][Full Text] [Related]
27. Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).
Weisbart RH; Billing R
Immunology; 1980 Apr; 39(4):577-82. PubMed ID: 6991400
[TBL] [Abstract][Full Text] [Related]
28. [Leukocyte migration inhibition test for functional evaluation of the T-lymphocyte population].
Bilynskaia KhZ; Loginskiĭ VE
Lab Delo; 1980; (5):316-7. PubMed ID: 6156295
[No Abstract] [Full Text] [Related]
29. Direct stimulation of lymphokine production by cephalothin.
Larson SE; DaMert GJ; Collins-Lech C; Sohnle PG
J Infect Dis; 1980 Aug; 142(2):265-72. PubMed ID: 6997406
[TBL] [Abstract][Full Text] [Related]
30. Ly phenotype of lymphocytes producing murine migration inhibitory factor (MIF).
Kühner AL; Cantor H; David JR
J Immunol; 1980 Sep; 125(3):1117-9. PubMed ID: 6997376
[TBL] [Abstract][Full Text] [Related]
31. [Leukocyte migration test following stimulation with protein factor of neutrophilic granulocytes (PMNL) in the peripheral blood of patients with psoriasis].
Ciborska L; Ruszczak Z; Kaszuba A; Trznadel-Budźko E
Z Hautkr; 1987 Mar; 62(5):410-4. PubMed ID: 2438852
[TBL] [Abstract][Full Text] [Related]
32. Migration inhibition and stimulation factors produced from peripheral blood lymphocyte cultures of sensitised guinea pigs.
Matsui Y; Oshima S
Asian Pac J Allergy Immunol; 1985 Dec; 3(2):151-5. PubMed ID: 3907650
[TBL] [Abstract][Full Text] [Related]
33. [Functional state of T-lymphocytes of the skin in patients with psoriasis].
Bogdanovich LI; Kozin VM; Adamchenko GP
Vestn Dermatol Venerol; 1984 Aug; (8):8-10. PubMed ID: 6385530
[No Abstract] [Full Text] [Related]
34. Specific lymphokine responses in cervical nodes of patients with laryngeal cancer.
Cortesina G; Beatrice F; Morra B; Barioglio MG; Poggio E; Bussi M; DiFortunato V; Sacchi M; Rendine S; Sartoris A
Laryngoscope; 1987 Jul; 97(7 Pt 1):843-7. PubMed ID: 3298902
[TBL] [Abstract][Full Text] [Related]
35. Cellular response to alpha-gliadin in untreated coeliac disease.
O'Farrelly C; Feighery C; Greally JF; Weir DG
Gut; 1982 Jan; 23(1):83-7. PubMed ID: 7035300
[TBL] [Abstract][Full Text] [Related]
36. Certain characteristics of human lymphocyte migration inhibitory factors (LyMIF) and the effect of ampicillin on their appearance in unstimulated and PHA-stimulated cultures.
Skopińska-Rózewska E; Madaliński W; Lukasik R
Acta Physiol Pol; 1983; 34(3):353-67. PubMed ID: 6372368
[TBL] [Abstract][Full Text] [Related]
37. Differential in vitro effects of etretinate and retinoic acid on the PHA and con A induced lymphocyte transformation, suppressor cell induction and leukocyte migration inhibitory factor (LMIF) production.
Soppi E; Tertti R; Soppi AM; Toivanen A; Jansén CT
Int J Immunopharmacol; 1982; 4(5):437-43. PubMed ID: 6215368
[TBL] [Abstract][Full Text] [Related]
38. In vitro culture of skin-homing T lymphocytes from inflammatory skin diseases.
Bang K; Lund M; Mogensen SC; Thestrup-Pedersen K
Exp Dermatol; 2005 May; 14(5):391-7. PubMed ID: 15854134
[TBL] [Abstract][Full Text] [Related]
39. [Studies on the pathogenic mechanism of hypersensitivity to antibacterial agents--correlations of leucocyte migration activating factor and leucocyte migration inhibitory factor with interleukin-2 and interferon-gamma].
Uno K
Arerugi; 1993 May; 42(5):656-64. PubMed ID: 8323465
[TBL] [Abstract][Full Text] [Related]
40. Effects of indomethacin on lymphocyte proliferation, suppressor cell function, and leukocyte migration inhibitory factor (lmif) production.
Soppi E; Eskola J; Ruuskanen O
Immunopharmacology; 1982 Jun; 4(3):235-42. PubMed ID: 6213582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
